ArticleTurkish journal of medical sciences2025
Do the amplitude ratios of sensory nerve action potentials in the lower extremities have any diagnostic utility in distal diabetic polyneuropathy?
Article in Turkish journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: To investigate the diagnostic sensitivity of sural sensory nerve action potential (SNAP) to medial femoral cutaneous nerve and dorsal sural to sural SNAP amplitude ratios in patients with diabetic polyneuropathy. Materials and methods: Sural/radial (SRAR), sural/medial femoral cutaneous (SMFAR), and dorsal sural/sural (DSSAR) SNAP amplitude ratios were calculated in 22 controls and 46 patients with type 2 diabetes mellitus. Combined sensory scores (superficial peroneal, sural, dorsal sural, and medial plantar SNAPs), and amplitude ratio scores (SRAR, DSSAR, and SMFAR) were assessed. The parameters were compared statistically between the patient and control groups. Results: All SNAP amplitudes were significantly lower in patients as compared with those of the controls. Reduced medial plantar SNAP amplitude was the most frequent abnormality in the patient group. DSSAR and SMFAR, but not SRAR were found to have significant value in differentiating patients from controls with low sensitivity and moderate specificity. The combined sensory score improved the diagnostic accuracy for diabetic polyneuropathy, while the other combined scores add no additional value in this respect. Conclusion: Distal nerve conduction studies (NCSs) are most useful in diagnosing mild diabetic polyneuropathy. Although DSSAR and SMFAR can be moderately sensitive alternatives, particularly when used in combined scores, these ratios do not add any diagnostic value in patients with axonal polyneuropathies of similar severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.